Results 141 to 150 of about 5,159 (158)

Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease

Circulation, 2022
Michelle L O'Donoghue, Robert P Giugliano, Stephen D Wiviott   +2 more
exaly  

Long-term persistence with evolocumab treatment and sustained reductions in LDL-cholesterol levels over 30 months: Final results from the European observational HEYMANS study

Atherosclerosis, 2023
Kausik K Ray, Christoph Ebenbichler, Anja Vogt   +2 more
exaly  

Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials

European Heart Journal, 2022
Paul Guédeney, Gennaro Giustino, Sabato Sorrentino   +2 more
exaly  

Evolocumab in patients with homozygous familial hypercholesterolemia in India

Journal of Clinical Lipidology, 2021
Andrea Ruzza, Jps Sawhney, Vimal Mehta   +2 more
exaly  

Indirect comparison of the efficacy and safety of alirocumab and evolocumab: a systematic review and network meta-analysis

European Heart Journal - Cardiovascular Pharmacotherapy, 2020
Paul Guédeney, Sabato Sorrentino, Gennaro Giustino   +2 more
exaly  

Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis

Stroke, 2020
Robert P Giugliano, Terje R Pedersen, Jeffrey L Saver   +2 more
exaly  

LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial

European Journal of Preventive Cardiology, 2021
Ioanna Gouni-Berthold, Robert P Giugliano, Terje R Pedersen   +2 more
exaly  

Effect of Evolocumab on Atherogenic Lipoproteins During the Peri- and Early Postinfarction Period

Circulation, 2020
Thorsten M Leucker, Michael J Bláha, Steven R Jones   +2 more
exaly  

Anti-PCSK9 Monotherapy for Hypercholesterolemia

Journal of the American College of Cardiology, 2014
Michael J Koren, Joel M Neutel, Maria Laura Monsalvo   +2 more
exaly  

Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease

Circulation, 2018
Marc P Bonaca, Robert P Giugliano, Anthony C Keech   +2 more
exaly